Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factor

J Thorac Oncol. 2011 Nov;6(11 Suppl 4):S1810-1. doi: 10.1097/01.JTO.0000407568.45147.43.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / metabolism
  • Clinical Trials as Topic
  • Hepatocyte Growth Factor / metabolism*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / metabolism
  • Proto-Oncogene Proteins c-met / antagonists & inhibitors*
  • Proto-Oncogene Proteins c-met / metabolism*

Substances

  • Antineoplastic Agents
  • Hepatocyte Growth Factor
  • Proto-Oncogene Proteins c-met